Search results for "Apparato cardiovascolare"

showing 10 items of 310 documents

Influence of climatic variables on acute myocardial infarction hospital admissions

2009

BACKGROUND: Seasonal peaks in acute myocardial infarction (AMI) incidence have been widely reported. Weather has been postulated to be one of the elements at the basis of this association. The aim of our study was to determine the influence of seasonal variations and weather on AMI hospital admissions. METHODS: We correlated the daily number of AMI cases admitted to a western Sicily hospital over twelve years and weather conditions on a day-to-day basis. Information on temperature, humidity, wind force and direction, precipitation, sunny hours and atmospheric pressure was obtained from the local Birgi Air Force base. A total of 3918 consecutive patients were admitted with AMI over the perio…

MaleMultivariate statisticsmedicine.medical_specialtyClimateMyocardial InfarctionPatient AdmissionEpidemiologymedicineHumansMyocardial infarctionIntensive care medicineWeatherAgedRetrospective StudiesAged 80 and overbusiness.industryIncidence (epidemiology)Climatic variablesHumidityRetrospective cohort studyMiddle AgedSeasonalitymedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareConfidence intervalCold TemperatureHospitalizationItalyClimatic variables acute myocardial infarctionFemaleSeasonsCardiology and Cardiovascular MedicinebusinessDemographyInternational Journal of Cardiology
researchProduct

Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era

2020

Abstract Aims To evaluate the impact of the COVID-19 pandemic on patient admissions to Italian cardiac care units (CCUs). Methods and Results We conducted a multicentre, observational, nationwide survey to collect data on admissions for acute myocardial infarction (AMI) at Italian CCUs throughout a 1 week period during the COVID-19 outbreak, compared with the equivalent week in 2019. We observed a 48.4% reduction in admissions for AMI compared with the equivalent week in 2019 (P < 0.001). The reduction was significant for both ST-segment elevation myocardial infarction [STEMI; 26.5%, 95% confidence interval (CI) 21.7–32.3; P = 0.009] and non-STEMI (NSTEMI; 65.1%, 95% CI 60.3–70.3; P …

MaleMyocardial Infarction030204 cardiovascular system & hematologySettore MED/110302 clinical medicineAcute myocardial infarction Cardiac care units STEMI Aged Aged 80 and over COVID-19 Female Hospitalization Humans Italy Male Middle Aged SARS-CoV-2 Betacoronavirus Coronavirus Infections Myocardial Infarction Pandemics Pneumonia ViralCase fatality rate80 and overMedicine030212 general & internal medicineMyocardial infarctionViralAged 80 and overAcute myocardial infarction; Cardiac care units; COVID-19; SARS-CoV2; STEMI; Aged; Aged 80 and over; Female; Hospitalization; Humans; Italy; Male; Middle Aged; Betacoronavirus; Coronavirus Infections; Myocardial Infarction; Pandemics; Pneumonia ViralMiddle AgedHospitalizationItalyFemaleCardiology and Cardiovascular MedicineCoronavirus InfectionsHumanmedicine.medical_specialtyPneumonia ViralFast Track Clinical ResearchCardiac care unitsAcute myocardial infarctionSTEMI03 medical and health sciencesBetacoronavirusCardiac care unitHumansAcute myocardial infarction; COVID-19; Cardiac care units; SARS-CoV2; STEMIcardiovascular diseasesPandemicsAgedBetacoronaviruPandemicbusiness.industryCoronavirus InfectionSARS-CoV-2COVID-19Pneumoniamedicine.diseaseacute myocardial infarction; cardiac care units; COVID-19; SARS-CoV2; STEMIConfidence intervalRelative riskEmergency medicineSettore MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLARESARS-CoV2Myocardial infarction complicationsObservational studyMyocardial infarction diagnosisbusinessComplication
researchProduct

Usefulness of microalbuminuria in cardiovascular risk stratification of essential hypertensive patients

2004

<i>Background/Aims:</i> To evaluate the influence of microalbuminuria (albumin excretion rate – AER) determination and echocardiography (ECHO) on cardiovascular risk stratification, initially performed according the 1999 WHO/ISH guidelines by using only routine diagnostic procedures with or without fundal examination. <i>Methods:</i> 312 essential hypertensives attending our institution were studied retrospectively. Cardiovascular risk was assessed in a semiquantitative way using four categories of absolute cardiovascular disease risk (low, medium, high and very high risk), as proposed by the 1999 WHO/ISH guidelines, on the basis of data on the average 10-year risk o…

MaleNephrologymedicine.medical_specialtySettore MED/09 - Medicina Internaendocrine system diseasesMicroalbuminuria. Cardiovascular risk. Left ventricular hypertrophy. Hypertension.Albumin excretion rateurologic and male genital diseasesLeft ventricular hypertrophyRisk AssessmentRetinaInternal medicinemedicineAlbuminuriaHumansRisk factorRetrospective StudiesSettore MED/14 - NefrologiaProteinuriabusiness.industryGeneral MedicineMiddle AgedPrognosismedicine.diseaseSettore MED/11 - Malattie Dell'Apparato Cardiovascolarefemale genital diseases and pregnancy complicationsSurgeryOphthalmoscopyCardiovascular DiseasesEchocardiographyNephrologyHypertensionRisk stratificationCardiologyFemaleMicroalbuminuriamedicine.symptombusiness
researchProduct

Marshall's vein persistence: A rare and occasional finding during pacemaker implantation

2012

In adults the oblique vein of Marshall is usually absent or very thin, and it is hard to be found. In this case report we describe a case of persistence observed during pacemaker implantation.

MalePacemaker ArtificialVena Cava SuperiorSettore MED/09 - Medicina InternaHumansPhlebographyMiddle AgedAtrioventricular BlockSettore MED/11 - Malattie Dell'Apparato CardiovascolareMARSHALL’S VEIN PERSISTENCE PACEMAKER IMPLANTATION
researchProduct

Vorapaxar in the secondary prevention of atherothrombotic events

2012

BACKGROUND: Thrombin potently activates platelets through the protease-activated receptor PAR-1. Vorapaxar is a novel antiplatelet agent that selectively inhibits the cellular actions of thrombin through antagonism of PAR-1. METHODS: We randomly assigned 26,449 patients who had a history of myocardial infarction, ischemic stroke, or peripheral arterial disease to receive vorapaxar (2.5 mg daily) or matching placebo and followed them for a median of 30 months. The primary efficacy end point was the composite of death from cardiovascular causes, myocardial infarction, or stroke. After 2 years, the data and safety monitoring board recommended discontinuation of the study treatment in patients …

MalePyridines[SDV]Life Sciences [q-bio]Myocardial InfarctionMedizinKaplan-Meier Estimate030204 cardiovascular system & hematologyBrain IschemiaLactones0302 clinical medicineMESH: Peripheral Arterial DiseaseSecondary PreventionMESH: Double-Blind Method030212 general & internal medicineMyocardial infarctionStrokeVorapaxarMESH: AgedAspirinMESH: Middle AgedMESH: RiskCardiovascular diseases [NCEBP 14]MESH: Secondary PreventionHazard ratioMESH: Brain IschemiaGeneral MedicineMiddle AgedClopidogrel3. Good healthStrokeMESH: Receptor PAR-1MESH: Myocardial Infarctionvorapaxar secondary prevention atherothrombotic eventsCardiovascular DiseasesMESH: Platelet Aggregation InhibitorsAnesthesiaRetreatmentPlatelet aggregation inhibitorFemaleIntracranial HemorrhagesMESH: HemorrhageMESH: Intracranial HemorrhagesMESH: Lactonescirculatory and respiratory physiologymedicine.drugRiskISQUEMIA CEREBRALHemorrhagePlaceboMESH: StrokePeripheral Arterial Disease03 medical and health sciencesDouble-Blind Method[INFO.INFO-IM]Computer Science [cs]/Medical ImagingmedicineHumansReceptor PAR-1MESH: RetreatmentMESH: Kaplan-Meier EstimateAgedMESH: Humansbusiness.industryMESH: PyridinesMESH: Cardiovascular Diseasesmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareMESH: MalebusinessMESH: FemalePlatelet Aggregation Inhibitors
researchProduct

Anticoagulant drugs in noncompaction: A mandatory therapy?

2008

BACKGROUND: Noncompaction of left ventricular myocardium is a rare congenital cardiomyopathy resulting from an incomplete myocardial morphogenesis that leads to the persistence of the embryonic myocardium. This condition is characterized by a thin compacted epicardial and an extremely thickened endocardial layer with prominent trabeculations and deep intertrabecular recesses. It is not clear, in noncompaction of myocardium, whether intertrabecular recesses could be responsible for thrombi formation and thromboembolic complications. METHODS: The prevalence of stroke and echocardiographic finding of thrombus was evaluated in a continuous series of 229 patients (men and women) affected by nonc…

MaleRegistrieTime FactorsEmbolismAdministration OralHeart VentricleRisk FactorsRegistriesStrokeIschemic strokeAnticoagulantCongenital cardiomyopathyGeneral MedicineMiddle AgedStrokeAnticoagulant drugsCardiologycardiovascular systemFemaleAnticoagulant drugs noncompactionCardiomyopathiesCardiology and Cardiovascular MedicineHumanAdultHeart Defects Congenitalmedicine.medical_specialtyStroke etiologyTime Factormedicine.drug_classIsolated left ventricular noncompactionHeart Ventriclesanticoagulant; embolism; ischemic stroke; Isolated left ventricular noncompactionInternal medicineThromboembolismmedicineHumanscardiovascular diseasesThrombusNoncompactionCardiomyopathiebusiness.industryRisk FactorAnticoagulantAnticoagulantsInfantmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareEmbolismIschemic strokeThrombuLeft ventricular myocardiumbusiness
researchProduct

Pharmacological treatment of patients with chronic critical limb ischemia: L-propionyl-carnitine enhances the short-term effects of PGE-1.

2009

Purpose. To evaluate the therapeutic effects of L-propionyl-carnitine (LPC) in patients with critical limb ischemia (CLI), as defined by the TASC guidelines. Methods. The study, double-blinded, randomised, assessed intravenous infusion of LPC 1.2 g/day in combination with PGE-1, 60 mg/day (LPC group: 37 patients), or PGE-1 only (control group: 38 patients) in a total of 75 patients suffering from CLI. Treatment duration was 20 days. We evaluated rest pain, maximum walking distance (MWD) and skin ulcer size. Results. In both groups we observed a significant reduction in pain score and ulcer size and an increase in MWD. In the patients treated with the combination, the improvement was greater…

MaleSettore MED/09 - Medicina InternaCardiotonic AgentsVasodilator AgentsProstaglandin E1IschemiaPainWalkinglaw.inventionchemistry.chemical_compoundRandomized controlled trialDouble-Blind MethodlawIschemiaCarnitinemedicineHumansPharmacology (medical)CarnitineAlprostadilProstaglandin E1Infusions IntravenousAgedPharmacologyLegCritical Limb Ischemiabusiness.industryTherapeutic effectLeg UlcerDrug SynergismGeneral MedicineCritical limb ischemiaL-PropionylcarnitineSkin ulcerMiddle Agedmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareTreatment OutcomechemistryAnesthesiaChronic Diseaselipids (amino acids peptides and proteins)Drug Therapy CombinationFemalemedicine.symptomCardiology and Cardiovascular MedicineClaudicationbusinessmedicine.drugCardiovascular drugs and therapy
researchProduct

Serum uric acid is not independently associated with plasma renin activity and plasma aldosterone in hypertensive adults

2017

Background and Aims In experimental investigations conducted in rats, raising serum uric acid (SUA) levels resulted in the stimulation of intrarenal renin expression. Studies in humans exploring the association of SUA with plasma renin activity (PRA) yielded conflicting results. Moreover, little is known about the relationship of SUA with plasma aldosterone concentration (PAC). The study aimed to assess the relationship between SUA levels, PRA, and PAC and the influence of age, gender, body mass index (BMI), and hyperuricemia on these relationships in subjects with essential hypertension (EH). Methods and Results We enrolled 372 hypertensive patients (mean age 45 ± 12 years, men 67%) with u…

MaleSettore MED/09 - Medicina InternaEndocrinology Diabetes and MetabolismMedicine (miscellaneous)030204 cardiovascular system & hematologyEssential hypertensionKidneyPlasma renin activityRenin-Angiotensin Systemchemistry.chemical_compound0302 clinical medicineRisk FactorsReninNutrition and Dietetic030212 general & internal medicineHyperuricemiaAldosteroneAdiposityNutrition and DieteticsAldosteroneAge FactorsMiddle AgedHypertensionBlood pressureFemaleCardiology and Cardiovascular MedicineAdultArterial hypertensionmedicine.medical_specialtyRenal functionHyperuricemiaEssential hypertension03 medical and health sciencesSex FactorsPlasma renin activityPlasma aldosteroneInternal medicinemedicineHumansSettore MED/14 - NefrologiaCreatinineChi-Square Distributionbusiness.industrymedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareEndocrinologyCross-Sectional StudieschemistryMultivariate AnalysisLinear ModelsUric acidbusinessBody mass indexUric acidBiomarkers
researchProduct

Plasma aldosterone and its relationship with left ventricular mass in hypertensive patients with early-stage chronic kidney disease

2014

Plasma aldosterone concentrations (PACs) are often increased in the advanced stages of chronic kidney disease (CKD); however, PAC has not been fully investigated in early CKD. Moreover, little is known about the relationship between aldosteronemia and left ventricular (LV) mass in subjects with mild-to-moderate CKD. The study objectives were to analyze PAC, LV mass (LVM), LV geometry and their relationships, in a group of hypertensive patients with stage I-III CKD. One hundred ninety-five hypertensive patients with stage I-III CKD were enrolled and compared with a control group of 82 hypertensive patients without renal dysfunction. LVM was higher in subjects with CKD than in the control gro…

MaleSettore MED/09 - Medicina InternaPhysiologyBlood PressureKidney Function Testsurologic and male genital diseasesMuscle hypertrophychemistry.chemical_compoundAldosteroneAldosteroneMedicine (all)ConfoundingMiddle Agedfemale genital diseases and pregnancy complicationsleft ventricular geometrymedicine.anatomical_structureleft ventricular maCreatinineHypertensionCardiologyFemaleHypertrophy Left VentricularWaist CircumferenceCardiology and Cardiovascular MedicineHumanAdultmedicine.medical_specialtyRenal functionYoung AdultInternal medicineCKDInternal MedicinemedicineHumansRenal Insufficiency ChronicAgedSettore MED/14 - NefrologiaCreatinineKidney Function Testbusiness.industryCardiovascular riskmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareUric AcidEndocrinologyBlood pressurechemistryVentricleplasma aldosteronebusinessKidney diseaseHypertension Research
researchProduct

Subclinical atherosclerosis and fetuin-A plasma levels in essential hypertensive patients

2012

The intima-media thickness (IMT) is considered as a surrogate marker for atherosclerotic disease. The aim of this study was to analyze the relationship of carotid IMT with fetuin-A in patients with essential hypertension (EH) and normal renal function. The plasma levels of fetuin-A, interleukin 6 (IL-6), tumor necrosis factor-α (TNF-α) and the biomarker of oxidative stress 8-iso-PGF2alpha were assayed in samples from 105 untreated EH patients. Carotid IMT measurements were also performed. EH was studied overall and after dividing in EH with IMT ≥ and 0.9 mm (AUC (area under the curve) 0.738, P<0.0001). Our results suggest that in EH, fetuin-A is associated with the IMT independently of oxid…

MaleSettore MED/09 - Medicina Internaalpha-2-HS-GlycoproteinPhysiologyDinoprostKidneyEssential hypertensionmedicine.disease_causeCarotid Intima-Media ThicknessGastroenterologyatherosclerosiRisk FactorsMedicinebiologyArea under the curveMiddle Agedmusculoskeletal systemHypertensioncardiovascular systemRegression AnalysisBiomarker (medicine)FemaleEssential HypertensionCardiology and Cardiovascular MedicineAdultmedicine.medical_specialtyRenal functionPredictive Value of TestsInternal medicineInternal MedicineHumanscardiovascular diseasesintima-media thicknessInterleukin 6Settore MED/14 - NefrologiaInterleukin-6Tumor Necrosis Factor-alphabusiness.industrySurrogate endpointAtherosclerosismedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareFetuinfetuin-AOxidative StressCross-Sectional StudiesEndocrinologyinflammationCase-Control Studiesbiology.proteinbusinessBiomarkersOxidative stressHypertension Research
researchProduct